Balance Sheet for Anika Therapeutics Inc. (ANIK)

$ 45.43   -1.68 (-3.57%) Volume: 114.5k 4:00 PM EST 17-Jan-2020
After Hours:  $ 45.43 0.00 (0.00%) Volume: 2.01k 4:30 PM EST 17-Jan-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Cash and Equivalents 89,042 133,256 104,261 110,707 100,156
Restrictable Cash - - - - -
Marketable Securities 69,972 24,000 20,500 27,751 6,750
Accounts Receivable 20,775 23,825 27,598 21,652 17,152
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 20,775 23,825 27,598 21,652 17,152
Inventories, Raw Materials 13,688 11,296 5,884 5,780 6,162
Inventories, Work in Progress 4,626 6,062 5,559 5,656 3,041
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 6,819 4,677 4,540 3,502 3,204
Inventories, Other 25,133 22,035 15,983 14,938 12,407
Inventories, Adjustments & Allowances - - - - -
Inventories 25,133 22,035 15,983 14,938 12,407
Prepaid Expenses 1,854 3,211 2,098 1,385 1,371
Current Deferred Income Taxes - - - 4,357 1,189
Other Current Assets - - - - -
Total Current Assets 206,776 206,327 170,440 176,433 137,836
Land and Improvements - - - - -
Buildings and Improvement 33,801 31,459 27,796 27,622 27,589
Machinery, Furniture and Equipment 41,660 39,084 28,582 25,752 25,472
Construction in Progress 2,720 5,830 22,695 11,274 559
Fixed Assets, Other - - - - -
Fixed Assets, Total 78,181 76,373 79,073 64,648 53,620
Gross Fixed Assets 78,181 76,373 79,073 64,648 53,620
Accumulated Depreciation (24,070) (20,190) (26,777) (24,540) (21,951)
Net Fixed Assets 54,111 56,183 52,296 40,108 31,669
Intangibles 9,191 10,635 10,227 11,656 14,895
Cost in Excess 7,851 8,218 7,214 7,482 8,339
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 1,064 1,254 69 - -
Total Non-Current Assets 72,217 76,290 69,806 59,315 54,972
Total Assets 278,993 282,617 240,246 235,748 192,808
Liabilities [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Accounts Payable 3,143 6,747 2,303 8,302 1,201
Short Term Debt - - - - -
Notes Payable - - - - -
Accrued Expenses 3,315 3,433 3,176 1,696 1,980
Accrued Liabilities 3,315 3,433 3,176 1,696 1,980
Deferred Revenues 126 - - 209 25
Current Deferred Income Taxes (1,817) (1,198) (712) (1,594) (8,811)
Other Current Liabilities 4,705 2,893 3,320 7,071 2,767
Total Current Liabilities 11,289 13,073 8,799 17,278 5,973
Long Term Debt - - - - -
Deferred Income Tax 3,542 5,393 6,548 6,775 7,741
Other Non-Current Liabilities 550 660 2,126 847 996
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 4,092 6,053 8,674 7,622 8,737
Total Liabilities 15,381 19,126 17,473 24,900 14,710
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 263,612 263,491 222,773 210,848 178,098
Common Par 142 147 146 150 149
Additional Paid in Capital 50,763 68,617 61,735 81,685 77,540
Cumulative Translation Adjustments (5,526) (4,784) (7,317) (6,649) (4,495)
Retained Earnings 218,233 199,511 168,209 135,662 104,904
Treasury Stock - - - - -
Other Equity Adjustments (5,526) (4,784) (7,317) (6,649) (4,495)
Total Capitalization 263,612 263,491 222,773 210,848 178,098
Total Equity 263,612 263,491 222,773 210,848 178,098
Total Liabilities & Shareholder's Equity 278,993 282,617 240,246 235,748 192,808
Cash Flow 13,184 31,816 32,547 30,758 38,319
Working Capital 195,487 193,254 161,641 159,155 131,863
Free Cash Flow 30,262 31,832 9,787 29,839 38,425
Invested Capital 263,612 263,491 222,773 210,848 178,098
Shares Outstanding - Common Class Only 14,210 14,688 14,627 15,037 14,852
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 14,210 14,688 14,627 15,037 14,852
Total Common Shares Outstanding 14,210 14,688 14,627 15,037 14,852
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 14,442 14,575 14,682 14,934 14,678
Diluted Weighted Shares Outstanding 14,689 15,068 15,116 15,321 15,269